Holen Sie sich die Stockscreener-App
58.66
6.56%
-4.12
Handel nachbörslich:
58.77
0.11
+0.19%
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Rosen Law Firm Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action InvestigationTEM - PR Newswire
Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Tempus AI (TEM) Stock Sees Intraday Recovery, Closes Slightly Lower Amidst Strong Recent Gains - Daily Chhattisgarh News
3 AI Stocks Flying Under the Radar - TradingView
Green Alpha Advisors LLC Acquires 18,628 Shares of Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
RFG Advisory LLC Takes $1.83 Million Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
7,220 Shares in Tempus AI, Inc. (NASDAQ:TEM) Acquired by ProShare Advisors LLC - MarketBeat
Why Tempus AI, Inc. (TEM) Skyrocketed On Monday - MSN
TEMPUS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Insider Sell Alert: Jennifer Doudna Sells Shares of Tempus AI In - GuruFocus
Did You Suffer Losses in Tempus AI, Inc. (TEM)? Contact Levi & Korsinsky About Securities Fraud Claims - ACCESS Newswire
Fraud Investigation: Levi & Korsinsky Investigates Tempus AI, Inc. (TEM) on Behalf of Shareholders - ACCESS Newswire
Tempus AI (NASDAQ:TEM) Trading Up 2.9%Here's Why - MarketBeat
Decoding Tempus AI's Options Activity: What's the Big Picture? - Nasdaq
Ark Invest prioritizes companies with AI - Traders Union
Tempus AI short report addressed issues mostly known, says TD Cowen - MSN
Beyond LLMs: How Propense.ai & Tempus AI are Shaking up Legacy Industries - TradingView
Tempus AI Stock Price Down 3.1%: Why is TEM stock dropping? - Markets.com
Traders Buy High Volume of Tempus AI Call Options (NASDAQ:TEM) - Defense World
Two Sigma Advisers LP Invests $625,000 in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Top Medical Stocks To Research – June 2nd - Defense World
Best Artificial Intelligence Stocks To Watch Now – June 2nd - Defense World
Lost Money on Tempus AI, Inc. (TEM)? Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
TEM Investor Notice: Levi & Korsinsky Investigates Tempus AI, Inc. for Securities Law Violations - ACCESS Newswire
Tempus AI (NASDAQ:TEM) Stock Price Down 3.1%Here's Why - MarketBeat
Tempus AI (NASDAQ:TEM) Shares Gap DownTime to Sell? - MarketBeat
Tempus AI Unveils New Liquid Biopsy Assay for Early Immunotherapy Response Monitoring in Cancer - MSN
Future of healthcare? Tempus AI (TEM) quietly embeds 1,000+ AI agents in hospitals - Investorsobserver
TEM stock price analysis: Why Tempus AI Stock Up Today? - Markets.com
James J. Burns & Company LLC Raises Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
These 10 Stocks Blew Past Expectations - Insider Monkey
Why Tempus AI Stock Soared 15% Today - MSN
Levi & Korsinsky Investigating Whether Tempus AI, Inc. (TEM) Misled InvestorsSecurities Law Violations Possible - ACCESS Newswire
Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Tempus AI recovers 15% as Wall Street downplays Spruce Point allegations - Investing.com Australia
Tempus AI Expands Tempus One with EHR Integration, New AI Features - Insider Monkey
Tempus AI Sees Unusually Large Options Volume (NASDAQ:TEM) - MarketBeat
Tempus AI recovers after TD Cowen criticizes short report - Seeking Alpha
Tempus AI (NASDAQ:TEM) Stock Price Up 13.9%Still a Buy? - MarketBeat
Tempus AI, Inc. (TEM) Launches ‘Fuses’ to Power AI-Driven Precision Diagnostics - MSN
Tempus AI rebound, Meta's AI ad push, Broadcom earnings optimism - Yahoo Finance
TD Cowen maintains buy rating on Tempus AI stock after short report - Investing.com Nigeria
Tempus AI (NASDAQ:TEM) Sees Strong Trading VolumeHere's Why - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc.TEM - FinancialContent
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are ... - Eagle-Tribune
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - TradingView
Tempus AI Stock Rockets After Introduction Of Liquid Biopsy Assay For Cancer Treatment Monitoring: Retail Hopes For A 20% Rally - Asianet Newsable
Tempus AI jumps after hit from short seller’s report - Sherwood News
tempus AI Inc Class A call volume above normal and directionally bullish - TipRanks
Tempus AI, Inc. Class A Stocks Surge Amid Market Buzz - TipRanks
Tempus AI (TEM) Stock Skyrockets Over 13% on Strong Investor Demand - Daily Chhattisgarh News
Tempus AI (TEM) Stock Surges Over 13% on Nasdaq, Trades Above $62 - Daily Chhattisgarh News
Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Lost Investment in Tempus AI, Inc. (TEM)? Levi & Korsinsky Launches Securities Fraud Investigation - ACCESS Newswire
Tempus AI unveils liquid biopsy for cancer treatment monitoring By Investing.com - Investing.com Canada
Tempus AI unveils liquid biopsy for cancer treatment monitoring - Investing.com
Tempus Introduces xM, An Assay To Monitor Immunotherapy Response For Patients With Advanced Cancers - marketscreener.com
0.32%
5.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):